hexoral 2 mg/ml sprej za usnu sluznicu, otopina
mcneil healthcare (ireland) limited, tallaght, high street, office 5, 6 & 7, block 5, dublin, irska - heksetidin - sprej za usnu sluznicu, otopina - 2 mg/ml - urbroj: jedan ml otopine sadrži 2 mg heksetidina
damar 250 mg/1 tableta+ 25 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - karbidopa, леводопы - tableta - 250 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 250 mg levodopa i 25 mg karbidopa
entix 20 mg/1 ampula rastvor za injekciju
pharmavision bh d.o.o. - фуросемид - rastvor za injekciju - 20 mg/1 ampula - 1 ampula sa 2 ml rastvora za injekciju sadrži: 20 mg furosemida
ferrum sandoz 100mg tableta za žvakanje
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-podgorica - gvožđe (iii) hidroksid polimaltozni kompleks - tableta za žvakanje - 100mg
flosteron 7mg/ml suspenzija za injekciju
dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - betametazon - suspenzija za injekciju - 7mg/ml
kamfart (20mg + 10mg + 10mg + 10mg)/g krem
bosnalijek d.d. predstavniŠtvo crna gora - kamfor, metil salicilat, benzil nikotinat, mentol - krem - (20mg + 10mg + 10mg + 10mg)/g
heparin panpharma 25000i.j./5 ml rastvor za injekciju
"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - heparin - rastvor za injekciju - 25000i.j./5 ml
ferrum sandoz 50mg/5ml sirup
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-podgorica - gvožđe (iii) hidroksid polimaltozni kompleks - sirup - 50mg/5ml
xeljanz
pfizer europe ma eeig - Тофацитиниб - artritis, reumatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 i 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
angal 5 mg / 1 mg pastile
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - klorheksidindiklorid lidokainklorid - pastila - 5 mg + 1 mg - urbroj: jedna pastila sadrži 5 mg klorheksidindiklorida i 1 mg lidokainklorida